Roche Licenses Emulsion PCR Patents to Sysmex Inostics | GenomeWeb

NEW YORK (GenomeWeb News) — Roche said today that it has licensed its emulsion PCR patent portfolio to Sysmex Inostics.

Under the agreement, Sysmex Inostics receives a worldwide, non-exclusive, royalty-bearing license to Roche's patents covering emPCR, a technique in which individual DNA molecules are isolated in discrete water/oil emulsions including a capture bead and PCR amplification reagents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.